Evolent Health (EVH) Tops Q2 EPS by 1c

Evolent Health (NYSE: EVH) reported Q2 EPS of ($0.03), $0.01 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $144.5 million versus the consensus estimate of $141.81 million.

GUIDANCE:

Evolent Health sees Q3 2018 revenue of $570-585 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Robinhood prices $2B convertible notes offering due 2029